SynGenSys

Private

SheffieldHealthcare & Life Scienceshttps://www.syngensys.com/

Last Round

Seed

Apr 1, 2025

Total Funding Raised

$4.09M

Company Overview

SynGenSys is a biotechnology company that designs synthetic gene promoter systems to address bottlenecks in biopharma manufacturing and enhance cell and gene therapy development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

synthetic biologysynthetic gene promotersgene expression controlcell and gene therapyCGTpromoter engineeringgenerative biologycomputational design platformpromoter librarybiomanufacturingcustom promoter designgenetic circuit designbio-foundrytissue-specific expression

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SynGenSys Comps

Public and private peers based on sector, stage, and business model.

SynGenSys comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SynGenSys Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 1, 2025
Seed	Apr 3, 2024

View all Funding Rounds

SynGenSys Investors

Notable investors and investment history

SynGenSys investors
Investor	Rounds
UKRI Innovate UK	Seed
Takeda Ventures	Seed
The University of Sheffield	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 1, 2025
$1.84M round with Takeda Ventures and UKRI
Jun 21, 2024
Grew 40% QoQ, from 10 to 14 employees.

View all signals

SynGenSys Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SynGenSys Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SynGenSys's valuation, stock price, and market status.

Firmographic Details

HeadquartersSheffield

Employee Range18

Year Founded2021

Last FundingApr 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.